Medicus Pharma (NASDAQ:MDCX – Get Free Report) is projected to release its earnings data before the market opens on Friday, February 28th. Analysts expect Medicus Pharma to post earnings of ($0.32) per share for the quarter.
Medicus Pharma Price Performance
Shares of MDCX stock opened at $4.03 on Thursday. The stock has a 50-day moving average price of $2.95. Medicus Pharma has a 12 month low of $1.80 and a 12 month high of $6.00.
Analysts Set New Price Targets
A number of brokerages recently commented on MDCX. Brookline Capital Management upgraded Medicus Pharma to a “strong-buy” rating in a research report on Monday, December 23rd. Maxim Group initiated coverage on Medicus Pharma in a research report on Tuesday, December 17th. They issued a “buy” rating and a $10.00 price objective for the company.
About Medicus Pharma
Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.
See Also
- Five stocks we like better than Medicus Pharma
- What Are Earnings Reports?
- Buffett’s on the Sidelines – Should You Follow?
- Manufacturing Stocks Investing
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Why Are Stock Sectors Important to Successful Investing?
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
